Related Experiment Videos
[The dibasic amino acid metabolic disorders]
1Department of Pediatrics, Jikei University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 1, 1992
Summary
Ornithine metabolism disorders, including ornithine transcarbamylase deficiency (OTCD) and others, cause ammonia buildup. Molecular biology advancements enable early diagnosis and treatment for these rare genetic conditions.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Context:
- Urea cycle disorders involve abnormal metabolism of dibasic amino acids: ornithine, arginine, and lysine.
- Conditions discussed include ornithine transcarbamylase deficiency (OTCD), arginase deficiency (ARD), Hyperornithinemia-Hyperammonemia-Homocitrullinuria (H.H.H) syndrome, and Lysinuric protein intolerance (LPI).
- These disorders lead to the accumulation of urea precursors, primarily ammonia.
Purpose:
- To review recent knowledge on OTCD, ARD, H.H.H syndrome, and LPI.
- To highlight advancements in molecular biology relevant to these conditions.
- To emphasize the importance of early diagnosis and treatment.
Summary:
- Ornithine metabolism disorders result from defects in the urea cycle, leading to hyperammonemia.
- Dibasic amino acid metabolism is central to these conditions, affecting ornithine, arginine, and lysine pathways.
- Recent molecular biology breakthroughs facilitate earlier and more accurate diagnoses.
Impact:
- Improved diagnostic capabilities for rare genetic metabolic diseases.
- Potential for earlier therapeutic interventions, improving patient outcomes.
- Enhanced understanding of urea cycle disorders and their molecular underpinnings.